| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||||||
Net income | ||||||||||
-28,462 | 13,811 | 6,223 | 3,056 | -2,809 | -8,537 | -28,812 | 42,852 | -17,698 | 44,296 | 24,472 |
Adjustments to reconcile net income to net cash from operating activities | ||||||||||
Depreciation and amortization | ||||||||||
24,699 | 18,659 | 20,124 | 20,841 | 20,923 | 22,878 | 22,822 | 20,732 | 23,182 | 22,087 | 22,344 |
Amortization of debt costs and other assets | ||||||||||
3,778 | 1,024 | 1,712 | 1,569 | 1,752 | 3,621 | 720 | 1,737 | 1,239 | 471 | 248 |
Amortization of exclusivity agreements | ||||||||||
- | - | - | - | - | - | 1,546 | 1,289 | 374 | - | - |
Provision for doubtful accounts | ||||||||||
1,891 | -599 | 1,639 | 1,117 | 3,431 | 938 | 4,590 | 2,212 | 4,580 | 8,616 | 7,335 |
Deferred income taxes | ||||||||||
1,393 | -2,661 | 21,286 | 10,460 | -1,156 | -7,053 | 2,829 | 3,771 | -13,941 | 591 | -4,409 |
Share-based compensation | ||||||||||
21,540 | 18,930 | 12,557 | 15,966 | 7,214 | 5,724 | 6,267 | 6,303 | 6,648 | 8,138 | 10,752 |
Interest and loss on valuation of investment securities | ||||||||||
-5,000 | -3,050 | -5,585 | 2,700 | - | - | - | - | - | - | - |
Impairment of goodwill and certain assets | ||||||||||
- | - | - | - | - | - | 19,193 | - | - | - | - |
Gain on sale of assets | ||||||||||
- | - | - | - | 3,099 | - | - | - | - | - | - |
Change in fair value of contingent consideration | ||||||||||
29,140 | 3,069 | - | - | - | - | - | - | - | - | - |
Loss on refinancing of credit facility | ||||||||||
- | - | - | - | - | - | - | - | - | 550 | - |
Gain on interest rate swap | ||||||||||
- | - | - | - | - | - | - | - | - | 1,254 | 1,852 |
Gain on sale of Breg, Inc., net of tax | ||||||||||
- | - | - | - | - | - | - | 1,345 | - | 0 | - |
Net gain on sale of vascular operations, net of tax | ||||||||||
- | - | - | - | - | - | - | - | - | 8,521 | - |
Provision for inventory obsolescence | ||||||||||
- | - | - | - | - | - | - | - | - | - | 8,760 |
Excess income tax benefit on employee stock-based awards | ||||||||||
- | - | - | - | - | - | 82 | 1,020 | 1,737 | 2,417 | 25 |
Other | ||||||||||
-2,433 | -1,633 | -1,398 | -1,061 | -2,854 | -821 | -4,536 | -4,798 | -2,298 | -4,439 | -2,541 |
Changes in operating assets and liabilities, net of effects of acquisitions | ||||||||||
Accounts receivable | ||||||||||
11,037 | 3,706 | 6,562 | -392 | 1,547 | -6,138 | -28,562 | 11,128 | -6,645 | 16,645 | 23,858 |
Inventories | ||||||||||
5,712 | -9,698 | 15,645 | 5,284 | -3,136 | -8,109 | 3,213 | 384 | 12,705 | -9,767 | 8,941 |
Escrow receivable | ||||||||||
- | - | - | - | - | - | - | 41,537 | -32,562 | -2,049 | - |
Prepaid expenses and other current assets | ||||||||||
3,698 | 1,127 | 6,352 | -701 | -8,697 | -5,100 | -8,764 | 14,575 | -2,382 | 4,378 | 12 |
Other long-term assets | ||||||||||
- | - | - | - | 1,321 | 734 | 5,329 | 3,391 | 2,317 | 744 | - |
Accounts payable | ||||||||||
2,138 | -170 | 2,324 | -1,771 | 3,011 | -6,451 | -2,280 | 4,575 | 2,322 | -2,866 | -1,310 |
Charges related to U.S. Government resolutions | ||||||||||
- | - | - | - | - | - | - | -83,178 | 89,101 | - | - |
Other current liabilities | ||||||||||
-7,716 | -7,563 | -11,412 | 6,537 | 1,515 | 5,456 | 6,969 | -5,239 | 3,516 | -9,695 | 14,537 |
Payment of contingent consideration | ||||||||||
1,340 | - | - | - | - | - | - | - | - | - | - |
Other long-term assets and liabilities | ||||||||||
2,014 | 4,130 | -6,095 | -1,704 | 1,009 | 15,154 | -40 | 616 | 3,403 | -8,073 | - |
Net cash from operating activities | ||||||||||
32,033 | 49,918 | 38,972 | 59,076 | 43,610 | 51,164 | 67,042 | 10,162 | 64,730 | 42,313 | 50,582 |
Cash flows from investing activities | ||||||||||
Purchase of debt securities | ||||||||||
- | - | - | - | 15,250 | - | - | - | - | - | - |
Proceeds from sale of assets | ||||||||||
- | - | - | - | 4,800 | 32 | - | - | - | - | - |
Acquisition of business, net of cash acquired | ||||||||||
- | 44,294 | - | - | - | - | - | - | 5,250 | - | - |
Capital expenditures for property, plant and equipment | ||||||||||
18,997 | 13,592 | 14,665 | 16,432 | 27,197 | 18,069 | 24,787 | 27,994 | 24,965 | 25,844 | 20,915 |
Capital expenditures for intangible assets | ||||||||||
1,527 | 1,664 | 2,283 | 1,902 | 702 | 456 | 4,891 | 780 | 793 | 517 | 1,083 |
Asset acquisitions and other investments | ||||||||||
2,400 | 1,448 | -474 | - | - | - | - | - | - | - | - |
Other investing activities | ||||||||||
- | - | - | 3,613 | - | 1,457 | 1,374 | 714 | 468 | - | - |
Net proceeds from sale of other investments | ||||||||||
- | - | - | - | - | - | - | 878 | - | - | - |
Net cash from investing activities | ||||||||||
-22,924 | -60,998 | -16,474 | -21,947 | -38,349 | -19,950 | -31,052 | 125,163 | -31,476 | -2,146 | -22,287 |
Cash flows from financing activities | ||||||||||
Investment related to collaborative arrangement | ||||||||||
- | - | - | - | - | - | - | - | - | - | 2,000 |
Net proceeds from sale of Breg, Inc. | ||||||||||
- | - | - | - | - | - | - | 153,773 | - | - | 1,711 |
Net proceeds from the sale of vascular operations | ||||||||||
- | - | - | - | - | - | - | - | - | 24,215 | - |
Proceeds from issuance of common shares | ||||||||||
11,551 | 7,100 | 7,783 | 19,720 | 5,254 | 11,074 | 3,450 | 25,586 | 20,113 | 7,854 | 70 |
Payments related to withholdings for share-based compensation | ||||||||||
5,193 | 3,425 | 3,800 | 2,407 | 1,550 | 612 | - | - | - | - | - |
Payment of contingent consideration | ||||||||||
13,660 | - | - | - | - | - | - | - | - | - | - |
Payments related to finance lease obligation | ||||||||||
365 | - | - | - | - | - | - | - | - | - | - |
Payment of refinancing fees and debt issuance costs | ||||||||||
- | - | - | - | - | - | - | - | 758 | 4,266 | - |
Repayments of long-term debt | ||||||||||
- | - | - | - | - | 20,000 | 16 | 188,695 | 7,500 | 36,269 | 28,323 |
Payment of debt issuance costs and other financing activities | ||||||||||
3,021 | 682 | 445 | - | 1,825 | - | - | - | - | - | - |
Repayment of bank borrowings, net | ||||||||||
- | - | - | - | - | - | - | -1,297 | -2,561 | 1,723 | 248 |
Changes in restricted cash | ||||||||||
- | - | - | - | 34,424 | -10,662 | -2,375 | 25,799 | -24,178 | -11,290 | -612 |
Repurchase and retirement of common shares | ||||||||||
- | - | - | 63,425 | 11,575 | - | 39,494 | - | - | - | - |
Cash payment for purchase of minority interest in subsidiary | ||||||||||
- | - | - | - | - | - | - | - | 517 | - | 1,143 |
Excess income tax benefit on employee stock-based awards | ||||||||||
- | - | - | - | - | - | 82 | 1,020 | 1,737 | 2,417 | 25 |
Net cash from financing activities | ||||||||||
-10,688 | 2,993 | 3,538 | -46,112 | 24,728 | -20,200 | -38,353 | -137,587 | -13,664 | -39,831 | -29,955 |
Effect of exchange rate changes on cash | ||||||||||
-207 | -881 | 1,180 | -739 | -3,141 | -3,123 | 520 | 286 | -408 | -103 | 394 |
Net change in cash, cash equivalents, and restricted cash | ||||||||||
-1,786 | -8,968 | 27,216 | -9,722 | 26,848 | 7,891 | -1,843 | -1,976 | 19,182 | 233 | -1,266 |
Components of cash, cash equivalents and restricted cash at the end of period | ||||||||||
Repurchase of equity | ||||||||||
- | - | - | - | - | - | - | - | - | - | 220 |
Supplemental disclosure of cash flow information: | ||||||||||
Noncash investing activities: | ||||||||||
Intangible assets acquired in asset acquisitions | ||||||||||
1,600 | 2,015 | - | - | - | - | - | - | - | - | - |
Contingent consideration recognized at acquisition date | ||||||||||
- | 25,491 | - | - | - | - | - | - | - | - | - |
Cash paid during the year for: | ||||||||||
Interest | ||||||||||
- | - | - | - | 852 | 1,315 | 2,046 | 4,569 | 17,088 | 16,032 | 26,724 |
Income taxes | ||||||||||
- | - | - | - | 3,160 | 2,222 | 8,773 | 18,268 | 26,227 | 29,743 | 17,665 |